Skip to main content
SpringerLink
Log in

Human Immunodeficiency Virus Proteinase: Now, Then, What’s Next?

  • Chapter
Structure and Function of the Aspartic Proteinases

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 306))

Abstract

“Art is I; science is we.” Claude Bernard (1813-1878) Unlike in art, progress in the field of science comes as a result of the efforts of many people: “we” scientists. It emerges through the accumulation of work in countless laboratories, from those working for years on basic model systems, reaching all the way to those studying applied aspects of a specific system. This interdependent continuum of basic and applied aspects is exemplified in the evolving story of the human immunodeficiency virus protease (HIV PR).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. C. Dickson, R. Eisenman, H. Fan, E. Hunter and N. Teich, Protein biosynthesis and assembly, in: “RNA Tumor Viruses,” R. Weiss, N. Teich, H. Varmus and J. Coffin, eds., 2nd Ed., Cold Spring Harbor Lab., Cold Spring Harbor, NY (1984).

    Google Scholar 

  2. A. M. Skalka, Retroviral proteases: first glimpses at the anatomy of a processing machine, Cell 56: 911 (1989).

    Article  PubMed  CAS  Google Scholar 

  3. L. Ratner, W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, J. A. Rafalski, E. A. Whitehorn, K. Baumeister, L. Ivanoff, S. R. Petteway Jr, M. L. Pearson, J. A. Lautenberger, T. S. Papas, J. Ghrayeb, N. T. Chang, R. C. Gallo and F. Wong-Staal, Complete nucleotide sequence of the AIDS virus, HTLV-III, Nature 313: 277 (1985).

    Article  PubMed  CAS  Google Scholar 

  4. H. Toh, M. Ono, K. Saigo and T. Miyata, Retroviral protease-like sequence in the yeast transposon TY 1, Nature 315: 691 (1985).

    Article  CAS  Google Scholar 

  5. R. Sanchez-Pescador, M. D. Power, P. J. Barr, K. S. Steimer, M. M. Stempien, S. L. Brown-Shimer, W. W. Gee, A. Renard, A. Randolph, J. A. Levy, D. Dina and P. A. Luciw, Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2), Science 227: 484 (1985).

    Article  PubMed  CAS  Google Scholar 

  6. S. Wain-Hobson, P. Sonigo, O. Danos, S. Cole and M. Alizon, Nucleotide sequence of the AIDS virus, LAV, Cell 40: 9 (1985).

    Article  PubMed  CAS  Google Scholar 

  7. J. Leis, D. Baltimore, J. M. Bishop, J. Coffin, E. Fleissner, S. P. Goff, S. Oroszlan, H. Robinson, A. M. Skalka, H. M. Temin and V. Vogt, Standardized and simplified nomenclature for proteins common to all retroviruses, J. Virol. 62: 1808 (1988).

    PubMed  CAS  Google Scholar 

  8. F. M. Veronese, T. D. Copeland, A. L. DeVico, R. Rahman, S. Oroszlan, R. C. Gallo and M. G. Sarngadharan, Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV, Science 231: 1289 (1986).

    Article  CAS  Google Scholar 

  9. M. M. Lightfoote, J. E. Coligan, T. M. Folks, A. S. Fauci, M. A. Martin and S. Venkatesan, Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus, J. Virol. 60: 771 (1986).

    PubMed  CAS  Google Scholar 

  10. R. A. Kramer, M. D. Schaber, A. M. Skalka, K. Ganguly, F. Wong-Staal and E. P. Reddy, HTLV-III gag protein is processed in yeast cells by the virus pol-protease, Science 231: 1580 (1986).

    Article  PubMed  CAS  Google Scholar 

  11. U.C. Debouck, J. G. Gorniak, J. E. Strickler, T. D. Meek, B. W. Metcalf and M. Rosenberg, Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor, Proc. Natl. Acad. Sci. U.S.A. 84: 8903 (1987).

    Article  PubMed  CAS  Google Scholar 

  12. M. C. Graves, J. J. Lim, E. P. Heimer and R. A. Kramer, An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity, Proc. Natl. Acad. Sci. U.S.A. 85: 2449 (1988).

    Article  PubMed  CAS  Google Scholar 

  13. J. Mous, E. P. Heimer and S. F. J. Le Grice, Processing protease and reverse transcriptase from human immunodeficiency virus type I polyprotein in Escherichia coli, J. Virol. 62: 1433 (1988).

    PubMed  CAS  Google Scholar 

  14. E. P. Lillehoj, F. H. R. Salazar, R. J. Mervis, M. G. Raum, H. W. Chan, N. Ahmad and S. Venkatesan, Purification and structural characterization of the putative gag-pol protease of human immunodeficiency virus, J. Virol. 62: 3053 (1988).

    PubMed  CAS  Google Scholar 

  15. H.-G. Kräusslich, H. Schneider, G. Zybarth, C. A. Carter and E. Wimmer, Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli, J. Virol. 62: 4393 (1988).

    PubMed  Google Scholar 

  16. C.-Z. Giam and I. Boros, In vivo and in vitro autoprocessing of human immunodeficiency virus protease expressed in Escherichia coli, J. Biol. Chem. 263: 14617 (1988).

    PubMed  CAS  Google Scholar 

  17. J. Hansen, S. Billich, T. Schulze, S. Sukrow and K. Moelling, Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody, EMBO J. 7: 1785 (1988).

    PubMed  CAS  Google Scholar 

  18. N. E. Kohl, E. A. Emini, W. A. Schleif, L. J. Davis, J. C. Heimbach, R. A. F. Dixon, E. M. Scolnick and I. S. Sigal, Active human immunodeficiency virus protease is required for viral infectivity, Proc. Natl. Acad. Sci. U.S.A. 85: 4686 (1988).

    Article  PubMed  CAS  Google Scholar 

  19. C. Peng, B. K. Ho, T. W. Chang and N. T. Chang, Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity, J. Virol. 63: 2550 (1989).

    PubMed  CAS  Google Scholar 

  20. L. E. Henderson, T. D. Copeland, R. C. Sowder, A. M. Schultz and S. Oroszlan, Analysis of proteins and peptides purified from sucrose gradient banded HTLV-III, in: “Human retroviruses, cancer, and AIDS: approaches to prevention and therapy,” D. Bolognesi, ed., Alan R. Liss, Inc., New York (1988).

    Google Scholar 

  21. L. E. Henderson, R. E. Benveniste, R. Sowder, T. D. Copeland, A. M. Schultz and S. Oroszlan, Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne), J. Virol. 62: 2587 (1988).

    PubMed  CAS  Google Scholar 

  22. M. C. Graves, J. J. Lim, M. A. Zicopoulos, T. J. Stoller, M. C. Miedel, Y.-C. E. Pan, W. Danho and C. M. Nalin, Expression and characterization of human immunodeficiency virus-1 protease, in: “Proteases of Retroviruses,” V. Kostka, ed., Walter de Gruyter & Co., Berlin (1989).

    Google Scholar 

  23. H.-G. Kräusslich, R. H. Ingraham, M. T. Skoog, E. Wimmer, P. V. Pallai and C. A. Carter, Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides, Proc. Natl. Acad. Sci. U.S.A. 86: 807 (1989).

    Article  PubMed  Google Scholar 

  24. M. C. Graves, M. C. Meidel, Y.-C. E. Pan, M. Manneberg, H.-W. Lahm and F. Grüninger-Leitch, Identification of a human immunodeficiency virus-1 protease cleavage site within the 66,000 dalton subunit of reverse transcriptase, Biochem. Biophys. Res. Comm. 168: 30 (1990).

    Article  PubMed  CAS  Google Scholar 

  25. J. Kay and B. M. Dunn, Viral proteinases: weakness in strength, Biochim. Biophys. Acta 1048: 1 (1990).

    PubMed  CAS  Google Scholar 

  26. L. H. Pearl and W. R. Taylor, A structural model for the retroviral proteases, Nature 329: 351 (1987).

    Article  PubMed  CAS  Google Scholar 

  27. M. A. Navia, P. M. D. Fitzgerald, B. M. McKeever, C.-T. Leu, J. C. Heimbach, W. K. Herber, I. S. Sigal, P. L. Darke and J. P. Springer, Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1, Nature 337: 615 (1989).

    Article  PubMed  CAS  Google Scholar 

  28. A. Wlodawer, M. Miller, M. Jaskólski, B. K. Sathyanarayana, E. Baldwin, I. T. Weber, L. M. Selk, L. Clawson, J. Schneider and S. B. H. Kent, Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease, Science 245: 616 (1989).

    Article  PubMed  CAS  Google Scholar 

  29. R. Lapatto, T. Blundell, A. Hemmings, J. Overington, A. Wilderspin, S. Wood, J. R. Merson, P. J. Whittle, D. E. Danley, K. F. Geoghegan, S. J. Hawrylik, S. E. Lee, K. G. Scheid and P. M. Hobart, X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes, Nature 342: 299 (1989).

    Article  PubMed  CAS  Google Scholar 

  30. S. Seelmeier, H. Schmidt, V. Turk and K. von der Helm, Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A, Proc. Natl. Acad. Sci. U.S.A. 85: 6612 (1988).

    Article  PubMed  CAS  Google Scholar 

  31. S. F. J. Le Grice, J. Mills and J. Mous, Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation, EMBO J. 7: 2547 (1988).

    PubMed  Google Scholar 

  32. D. D. Loeb, C. A. Hutchison III, M. H. Edgell, W. G. Farmerie and R. Swanstrom, Mutational analysis of human immunodeficiency virus type 1 protease suggests functional homology with aspartic proteinases, J. Virol. 63: 111 (1989).

    PubMed  CAS  Google Scholar 

  33. P. L. Darke, C.-T. Leu, L. J. Davis, J. C. Heimbach, R. E. Diehl, W. S. Hill, R. A. F. Dixon and I. S. Sigal, Human immunodeficiency virus protease: bacterial expression and characterization of the purified aspartic protease, J. Biol. Chem. 264: 2307 (1989).

    PubMed  CAS  Google Scholar 

  34. A. D. Richards, R. Roberts, B. M. Dunn, M. C. Graves and J. Kay, Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases, FEBS Lett. 247: 113 (1989).

    Article  PubMed  CAS  Google Scholar 

  35. J. E. Strickler, J. Gorniak, B. Dayton, T. Meek, M. Moore, V. Magaard, J. Malinowski and C. Debouck, Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli, Proteins 6: 139 (1989).

    Article  PubMed  CAS  Google Scholar 

  36. A. G. Tomasselli, M. K. Olsen, J. O. Hui, DJ. Staples, T. K. Sawyer, R. L. Heinrikson and C.-S. C. Tomich, Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease, Biochemistry 29: 264 (1990).

    Article  PubMed  CAS  Google Scholar 

  37. J. Rittenhouse, M. C. Turon, R. J. Helfrich, K. S. Albrecht, D. Weigl, R. L. Simmer, F. Mordini, J. Erickson and W. E. Kohnbrenner, Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose, Biochem. Biophys. Res. Comm. 171: 60 (1990).

    Article  PubMed  CAS  Google Scholar 

  38. T. D. Meek, B. D. Dayton, B. W. Metcalf, G. B. Dreyer, J. E. Strickler, J. G. Gorniak, M. Rosenberg, M. L. Moore, V. W. Magaard and C. Debouck, Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease, Proc. Natl. Acad. Sci. U.S.A. 86: 1841 (1989).

    Article  PubMed  CAS  Google Scholar 

  39. A. D. Richards, L. H. Phylip, W. G. Farmerie, P. E. Scarborough, A. Alvarez, B. M. Dunn, Ph.-H. Hirel, J. Konvalinka, P. Strop, L. Pavlickova, V. Kostka and J. Kay, Sensitive, soluble chromogenic substrates for HIV-1 proteinase, J. Biol. Chem. 265: 7733 (1990).

    PubMed  CAS  Google Scholar 

  40. R. L. Shoeman, B. Höner, T. J. Stoller, C. Kesselmeier, M. C. Miedel, P. Traub and M. C. Graves, Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin and glial fibrillary acidic protein, Proc. Natl. Acad. Sci. U.S.A. 87: 6336 (1990).

    Article  PubMed  CAS  Google Scholar 

  41. J. Konvalinka, P. Strop, J. Velek, V. Cerna, V. Kostka, L. H. Phylip, A. D. Richards, B. M. Dunn and J. Kay, Sub-site preferences of the aspartic proteinase from the human immunodeficiency virus, HIV-1, FEBS Lett. 268: 35 (1990).

    Article  PubMed  CAS  Google Scholar 

  42. S. Billich, M.-T. Knoop, J. Hansen, P. Strop, J. Sedlacek, R. Mertz and K. Moelling, Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease, J. Biol. Chem. 263: 17905 (1988).

    PubMed  CAS  Google Scholar 

  43. J. Schneider and S. B. H. Kent, Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease, Cell 54: 363 (1988).

    Article  PubMed  CAS  Google Scholar 

  44. R. F. Nutt, S. F. Brady, P. L. Darke, T. M. Ciccarone, C. D. Colton, E. M. Nutt, J. A. Rodkey, C. D. Bennett, L. H. Waxman, I. S. Sigal, P. S. Anderson and D. F. Veber, Chemical synthesis and enzymatic activity of a 99-residue peptide with a sequence proposed for the human immunodeficiency virus protease, Proc. Natl. Acad. Sci. U.S.A. 85: 7129 (1988).

    Article  PubMed  CAS  Google Scholar 

  45. D. D. Loeb, R. Swanstrom, L. Everitt, M. Manchester, S. E. Stamper and C. A. Hutchison III, Complete mutagenesis of the HIV-1 protease, Nature 340: 397 (1989).

    Article  PubMed  CAS  Google Scholar 

  46. J. Erickson, D. J. Neidhart, J. VanDrie, D. J. Kempf, X. C. Wang, D. W. Norbeck, J. J. Plattner, J. W. Rittenhouse, M. Turon, N. Wideburg, W. E. Kohlbrenner, R. Simmer, R. Helfrich, D. A. Paul and M. Knigge, Design, activity, and 2.8 Å crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease, Science 249: 527 (1990).

    Article  PubMed  CAS  Google Scholar 

  47. G. B. Dreyer, B. W. Metcalf, T. A. Tomaszek, Jr., T. J. Carr, A. C. Chandler, III, L. Hyland, S. A. Fakhoury, V. W. Magaard, M. L. Moore, J. E. Strickler, C. Debouck and T. D. Meek, Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors, Proc. Natl. Acad. Sci. U.S.A. 86: 9752 (1989).

    Article  PubMed  CAS  Google Scholar 

  48. T. J. McQuade, A. G. Tomasselli, L. Liu, V. Karacostas, B. Moss, T. K. Sawyer, R. L. Heinrikson and W. G. Tarpley, A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation, Science 247: 454 (1990).

    Article  PubMed  CAS  Google Scholar 

  49. N. A. Roberts, J. A. Martin, D. Kinchington, A. V. Broadhurst, J. C. Craig, I. B. Duncan, S. A. Galpin, B. K. Handa, J. Kay, A. Kröhn, R. W. Lambert, J. H. Merrett, J. S. Mills, K. E. B. Parkes, S. Redshaw, A. J. Ritchie, D. L. Taylor, G. J. Thomas and P. J. Machin, Rational design of peptide-based HIV proteinase inhibitors, Science 248: 358 (1990).

    Article  PubMed  CAS  Google Scholar 

  50. M. Miller, J. Schneider, B. K. Sathyanarayana, M. V. Toth, G. R. Marshall, L. Clawson, L. Selk, S. B. H. Kent and A. Wlodawer, Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 Å resolution, Science 246: 1149 (1989).

    Article  PubMed  CAS  Google Scholar 

  51. A. L. Swain, M. M. Miller, J. Green, D. H. Rich, J. Schneider, S. B. H. Kent and A. Wlodawer, X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor, Proc. Nat. Acad. Sci., U.S.A. 87: 8805 (1990).

    Article  CAS  Google Scholar 

  52. P. M. D. Fitzgerald, B. M. McKeever, J. F. VanMiddlesworth, J. P. Springer, J. C. Heimbach, C.-T. Leu, W. K. Herber, R. A. F. Dixon and P. L. Darke, Crystallographic analysis of a complex between HIV-1 protease and acetyl-pepstatin at 2.0 Å resolution, J. Biol. Chem. 265: 14209 (1990).

    PubMed  CAS  Google Scholar 

  53. S. Erickson-Viitanen, J. Manfredi, P. Viitanen, D. E. Tribe, R. Tritch, C. A. Hutchison III, D. D. Loeb and R. Swanstrom, Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease, AIDS Res. Human Retroviruses 5: 577 (1989).

    Article  CAS  Google Scholar 

  54. K. Partin, H.-G. Kräusslich, L. Ehrlich, E. Wimmer and C. Carter, Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase, J. Virol. 64: 3938 (1990).

    PubMed  CAS  Google Scholar 

  55. P. L. Darke, R. F. Nutt, S. F. Brady, V. M. Garsky, T. M. Ciccarone, C.-T. Leu, P. K. Lumma, R. M. Freidinger, D. F. Veber and I. S. Sigal, HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins, Biochem. Biophys. Res. Comm. 156: 297 (1988).

    Article  PubMed  CAS  Google Scholar 

  56. A. G. Tomasselli, J. O. Hui, T. K. Sawyer, D. J. Staples, D. J. Fitz Gerald, V. K. Chaudhary, I. Pastan and R. L. Heinrikson, Interdomain hydrolysis of a truncated Pseudomonas exotoxin by the human immunodeficiency virus-1 protease, J. Biol. Chem. 265: 408 (1990).

    PubMed  CAS  Google Scholar 

  57. N. Margolin, W. Heath, E. Osborne, M. Lai and C. Vlahos, Substitutions at the P2′ site of gag pl7/p24 affect cleavage efficiency by HIV-1 protease, Biochem. Biophys. Res. Comm. 167: 554 (1990).

    Article  PubMed  CAS  Google Scholar 

  58. S. F. J. Le Grice, R. Ette, J. Mills and J. Mous, Comparison of the human immunodeficiency virus type 1 and 2 proteases by hybrid gene construction and trans-complementation, J. Biol. Chem. 264: 14902 (1989).

    PubMed  Google Scholar 

  59. R. L. Des Jarlais, G. L. Seibel, I. D. Kuntz, P. S. Furth, J. C. Alvarez, R. R. O. de Montellano, D. L. DeCamp, L. M. Babé and C. S. Craik, Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease, Proc. Natl. Acad. Sci. U.S.A. 87: 6644 (1990).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Genetics, Roche Research Center, Hoffmann-La Roche Inc, Nutley, New Jersey, 07110, USA

    Mary C. Graves

Authors
  1. Mary C. Graves
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Florida-College of Medicine, Gainesville, Florida, USA

    Ben M. Dunn

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Plenum Press, New York

About this chapter

Cite this chapter

Graves, M.C. (1991). Human Immunodeficiency Virus Proteinase: Now, Then, What’s Next?. In: Dunn, B.M. (eds) Structure and Function of the Aspartic Proteinases. Advances in Experimental Medicine and Biology, vol 306. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-6012-4_52

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-6012-4_52

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-6014-8

  • Online ISBN: 978-1-4684-6012-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation